IL10 and cancer: Our in vivo data support the existence of this crosstalk in ovarian cancer patients, in which we found that GLUL levels from ascitic fluid macrophages were increased proportionally according to the cancer stage and significantly correlated with the amount of both IL‐10 and NAA, measured in the ascitic fluid.